ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
204 hedge funds and large institutions have $3.06B invested in ChemoCentryx, Inc. in 2020 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 91 increasing their positions, 51 reducing their positions, and 32 closing their positions.
87% more call options, than puts
Call options by funds: $53.8M | Put options by funds: $28.8M
78% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 51
34% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 32
6% more funds holding
Funds holding: 193 → 204 (+11)
1% more capital invested
Capital invested by funds: $3.04B → $3.06B (+$20.2M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$103M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$51.5M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
+$43.5M |
| 4 |
D.E. Shaw & Co
New York
|
+$35M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$29.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$98.2M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$37.2M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$33.6M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$17.1M |
CCXI Hedge Fund Activity: Q3 2020 in Review
204 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2020, worth a combined $3.06B — up 0.66% from $3.04B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CCXI positions and 32 closed out — a net gain of 11 holders — while 91 added to existing stakes and 51 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $103M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $98.2M sold.
- 204 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2020, up from 193 in Q2 2020.
- Funds reported $3.06B of ChemoCentryx, Inc. stock for Q3 2020, up 0.66% quarter-over-quarter.
- 43 funds opened new ChemoCentryx, Inc. positions in Q3 2020 and 32 closed out, a net change of +11 holders.
- The largest ChemoCentryx, Inc. buyer in Q3 2020 was Wellington Management Group, an estimated $103M added.
- The largest ChemoCentryx, Inc. seller in Q3 2020 was Consonance Capital Management, an estimated $98.2M sold.
Based on aggregated 13F filings for Q3 2020.